SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001267602-21-000013
Filing Date
2021-03-05
Accepted
2021-03-04 18:36:02
Documents
97
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alim-20201231x10k.htm   iXBRL 10-K 4308418
2 EX-4.3 alim-20201231xex4_3.htm EX-4.3 22884
3 EX-21.1 alim-20201231xex21_1.htm EX-21.1 7068
4 EX-23.1 alim-20201231xex23_1.htm EX-23.1 3539
5 EX-31.1 alim-20201231xex31_1.htm EX-31.1 20786
6 EX-31.2 alim-20201231xex31_2.htm EX-31.2 20544
7 EX-32.1 alim-20201231xex32_1.htm EX-32.1 17355
  Complete submission text file 0001267602-21-000013.txt   14977518

Data Files

Seq Description Document Type Size
8 EX-101.SCH alim-20201231.xsd EX-101.SCH 74359
9 EX-101.CAL alim-20201231_cal.xml EX-101.CAL 90793
10 EX-101.DEF alim-20201231_def.xml EX-101.DEF 304366
11 EX-101.LAB alim-20201231_lab.xml EX-101.LAB 742262
12 EX-101.PRE alim-20201231_pre.xml EX-101.PRE 567798
13 EXTRACTED XBRL INSTANCE DOCUMENT alim-20201231x10k_htm.xml XML 3071003
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34703 | Film No.: 21715814
SIC: 2834 Pharmaceutical Preparations